Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fortrea Holdings Inc. (FTRE : NSDQ)

• Company Description    Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based in DURHAM, N.C. Number of Employees: 14,300

• Price / Volume Information    Yesterday's Closing Price: $13.22 Daily Weekly Monthly 20 Day Moving Average: 1,616,731 shares Shares Outstanding: 94.60 (millions) Market Capitalization: $1,250.61 (millions) Beta: 1.92 52 Week High: $18.67 52 Week Low: $3.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 37.28% 30.57% 12 Week 22.41% 13.16% Year To Date -23.36% -29.97%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 MOORE DRIVE - DURHAM,NC 27713 USA ph: 877-495-0816 fax: - investors@fortrea.com http://www.fortrea.com

• General Corporate Information    Officers Anshul Thakral - Chief Executive Officer;President Peter M. Neupert - Chairman of the Board Jill McConnell - Chief Financial Officer Robert Parks - Chief Accounting Officer Edward Pesicka - Director Peer Information Fortrea Holdings Inc. (CORR.) Fortrea Holdings Inc. (RSPI) Fortrea Holdings Inc. (CGXP) Fortrea Holdings Inc. (BGEN) Fortrea Holdings Inc. (GTBP) Fortrea Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 34965K107 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 94.60 Most Recent Split Date: (:1) Beta: 1.92 Market Capitalization: $1,250.61 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.18 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.80 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 40.91% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: 16.44 Trailing 12 Months: 23.61 PEG Ratio: 0.40 Price Ratios Price/Book: 2.38 Price/Cash Flow: 1.33 Price / Sales: 0.46 EPS Growth vs. Year Ago Period: 700.00% vs. Previous Quarter: 77.78% Sales Growth vs. Year Ago Period: -2.27% vs. Previous Quarter: -3.63% ROE 03/31/26 - 9.51 12/31/25 - 6.23 09/30/25 - 5.64 ROA 03/31/26 - 1.96 12/31/25 - 1.42 09/30/25 - 1.56 Current Ratio 03/31/26 - 0.95 12/31/25 - 0.98 09/30/25 - 1.00 Quick Ratio 03/31/26 - 0.95 12/31/25 - 0.98 09/30/25 - 1.00 Operating Margin 03/31/26 - 1.98 12/31/25 - 1.48 09/30/25 - 1.73 Net Margin 03/31/26 - -16.50 12/31/25 - -36.21 09/30/25 - -36.77 Pre-Tax Margin 03/31/26 - -16.51 12/31/25 - -36.10 09/30/25 - -37.04 Book Value 03/31/26 - 5.56 12/31/25 - 6.10 09/30/25 - 6.40 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 1.98 12/31/25 - 1.86 09/30/25 - 1.81 Debt-to-Capital 03/31/26 - 66.47 12/31/25 - 65.03 09/30/25 - 64.43

Powered by Zacks Investment Research ©